The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...
In “Immunotherapy in MSI-High and dMMR mCRC,” Dr. Strickler discusses how immune checkpoint inhibition has reshaped treatment ...
Combined MRI and ultrasound raised sensitivity for bowel and uterosacral ligament endometriosis but reduced specificity in a prospective cohort study. Investigators at Stockholm South General Hospital ...
Jordan Feld, MD, MPH, discusses bepirovirsen's approval and how capsid assembly modulators and gene editing could lead to a true hepatitis B cure. It is the first therapy approved with a primary ...
Karolinska Institutet’s Antoine Créon, MD, explains how alert fatigue, workflow, and center-level variation may have limited ...
Permanent standard time is the only option that ends biannual clock changes while keeping the body aligned with the sun, ...
Not every patient who carries Clostridioides difficile ( C diff) gets sick, and distinguishing colonization from true ...
Naima T. Joseph, MD, MPH, discusses why measles immunity screening in pregnancy is debated and how vaccination and counseling ...
Universal HCV testing, community-based prevention, and peer navigators can help curb a decade-long surge in new US hepatitis ...
Dr. Haumschild compares SGLT2 inhibitors and GLP-1 receptor agonists as evidence in both classes keeps evolving. He acknowledges GLP-1s carry real budget impact that payers cannot ...
Real-world evidence indicates that longer biologic dosing intervals are associated with higher persistence and fewer ...
As cancer treatments improve and patients are living longer, answering the question of who takes charge of care once active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results